Get the app
NSEHealthcare

Indegene Ltd (INDGN)

NSE · Healthcare · Health Information Services

₹591.75+3.24%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹1,063 cr
Revenue YoY
+39.7%
Net profit
₹116 cr
Profit YoY
-0.2%
EPS
₹4.81
EPS estimate
₹4.63
Net margin
10.9%

EPS came in at 4.81 against a street estimate of 4.63 — a beat of 3.9%.

Key statistics

Market cap
₹13,927 cr
P/E
34.8
Forward P/E
0.0
P/B
4.43
Book value
₹130.29
EPS (TTM)
₹16.63
52-week high
₹615.50
52-week low
₹412.19
50-day MA
₹544.48
200-day MA
₹509.59
Beta
0.74

Analyst view

with an average price target of ₹620.62.

Shareholding

Promoters
55.67%
Institutions
21.93%

Recent filings & reports

DocumentDate
Q1 FY27 earnings call
INDEGENE LIMITED – 28TH ANNUAL GENERAL MEETING SUMMARY August 13, 2026 --- HEADLINE NUMBERS • FY2025-26 Revenue: INR 35,105 million (USD 396.9 mill
2026-08-17
Investor presentation
INDEGENE LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹10,631 million (USD 112.5 million) — up 39.7% YoY in INR, u
2026-07-30
Annual report FY2026
INDEGENE LIMITED — FY 2025-26 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Final dividend declared: ₹2.25 per equity share for FY 2025-26 (₹2/- par valu
2026-07-17
Investor presentation · Q4 FY26
INDEGENE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: INR 35,105 million (INR 35.1 billion) • Revenue CAGR (FY21–FY26): 29.4% • Adjus
2026-05-28
Q4 FY26 earnings call
INDEGENE LIMITED – FY26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q4 FY26 revenue: ₹10,000 million (first quarter ever to cross this threshold
2026-05-06
Q3 FY26 earnings call
INDEGENE LIMITED - Q3 FY26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue Q3 FY26: INR 9,421 million ($113.3 million USD equivalent) • Reve
2026-02-04
Quarterly results · Q3 FY26
INDEGENE LIMITED – Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 FY2026 Revenue (Consolidated): ₹9,421 million, up 31% YoY vs ₹7,204 million in
2026-01-29
Q2 FY26 earnings call
INDEGENE LIMITED - Q2 FY'26 DOCUMENT SUMMARY HEADLINE NUMBERS • Q2 Revenue: INR 8,042 million, up 17.1% year-on-year and 5.7% quarter-on-quarter • Q
2025-11-03

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹2.25 / share
ex-date Jul 31, 2026
2026-07-31

Deals & corporate news

AnnouncementDate
Acquisition announced by the company
Indegene Limited has informed the Exchange about Acquisition
2026-03-01
Amalgamation/Merger of the company with another entity
Indegene Limited has informed the Exchange about Amalgamation/Merger
2026-01-01
Acquisition announced by the company
Indegene Limited has informed the Exchange about Acquisition
2025-12-31
Acquisition of another business completed
Indegene Limited has informed the Exchange about Acquisition
2025-11-10
Expands capabilities through two strategic acquisitions
Indegene Limited announced strong financial performance with 17% year-over-year revenue growth. The company also announced two strategic acquisitions to expand its capabilities and service o
2025-10-30

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Indegene Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.